EUVIMEDEUVIMED entdecken
Crossref

Development and Optimization of Stavudine Extended-Release Matrix Tablets Using Central Composite Design

Jyotimayee Singh, Santosh Kumar Dash, Swarupa Mayee Kalta, Abdul Sayeed Khan, Ashutosh Padhan, Tusarakanta Behera

International Journal of Drug Delivery Technology · 08.07.2026 · 16 (63s)

DOI: 10.25258/ijddt.16.63s.22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 08.07.2026. Verfasst von Jyotimayee Singh und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study aimed to develop and characterise stavudine-loaded extended-release (ER) tablets to overcome the limitations associated with its short biological half-life and frequent dosing in HIV therapy. Preformulation studies were conducted to evaluate the physicochemical, micromeritic, solubility, and thermal properties of stavudine. The drug exhibited acceptable flow characteristics, good thermal stability, and a melting point consistent with literature values, confirming its suitability for solid dosage form development. UV spectrophotometric methods were successfully developed and validated in various dissolution media, demonstrating excellent linearity and reliability for quantitative analysis. Solubility and dissolution studies revealed rapid drug release from pure stavudine, justifying the need for release-retarding polymers in ER formulations. Drug–excipient compatibility studies using ATR-FTIR and Differential Scanning Calorimetry confirmed the absence of chemical interactions between stavudine and selected excipients, including pregelatinized starch and dicalcium phosphate. Overall, the results establish stavudine as a suitable candidate for extended-release tablet formulation and provide a strong scientific foundation for further formulation optimisation using factorial design. The study supports the feasibility of developing a stable, effective, and patient-compliant ER dosage form of stavudine for improved therapeutic outcomes in HIV management.

Zitieren

APA

Singh, J., Dash, S. K., Kalta, S. M., Khan, A. S., Padhan, A., & Behera, T. (2026). Development and Optimization of Stavudine Extended-Release Matrix Tablets Using Central Composite Design. International Journal of Drug Delivery Technology, 16(63s). https://doi.org/10.25258/ijddt.16.63s.22

Vancouver

Singh J, Dash SK, Kalta SM, Khan AS, Padhan A, Behera T. Development and Optimization of Stavudine Extended-Release Matrix Tablets Using Central Composite Design. International Journal of Drug Delivery Technology. 2026;16(63s). doi:10.25258/ijddt.16.63s.22

BibTeX
@article{Singh2026,
  author = {Singh, Jyotimayee and Dash, Santosh Kumar and Kalta, Swarupa Mayee and Khan, Abdul Sayeed and Padhan, Ashutosh and Behera, Tusarakanta},
  title = {Development and Optimization of Stavudine Extended-Release Matrix Tablets Using Central Composite Design},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {63s},
  doi = {10.25258/ijddt.16.63s.22}
}
Kostenlos starten →